NASDAQ:NXTS Nexentis Technologies (NXTS) Stock Price, News & Analysis $1.80 -0.04 (-2.17%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsNews and TrendsOwnershipSEC Filings About Nexentis Technologies Stock (NASDAQ:NXTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nexentis Technologies alerts:Sign Up Key Stats Today's Range$1.69▼$1.8650-Day Range$1.48▼$5.9352-Week Range$1.43▼$58.75Volume35,871 shsAverage Volume43,991 shsMarket Capitalization$2.61 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. Its products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. The company's products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens. It also offers SpuDefender for controlling post-harvest potato sprouts; and FreshProtect to control spoilage-creating microorganisms on post-harvest citrus fruit. The company was formerly known as Save Foods, Inc. and changed its name to N2OFF, Inc. in March 2024. N2OFF, Inc. was incorporated in 2009 and is headquartered in Hod HaSharon, Israel. Read More Nexentis Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks18th Percentile Overall ScoreNXTS MarketRank™: Nexentis Technologies scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingNexentis Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageNexentis Technologies has only been the subject of 1 research reports in the past 90 days.Read more about Nexentis Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioNexentis Technologies has a P/B Ratio of 0.05. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.62% of the float of Nexentis Technologies has been sold short.Short Interest Ratio / Days to CoverNexentis Technologies has a short interest ratio ("days to cover") of 1.15, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nexentis Technologies has recently increased by 1.16%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNexentis Technologies does not currently pay a dividend.Dividend GrowthNexentis Technologies does not have a long track record of dividend growth. News and Social Media3.7 / 5News SentimentN/A News SentimentNexentis Technologies has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.98 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Nexentis Technologies this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Nexentis Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nexentis Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders6.52% of the stock of Nexentis Technologies is held by insiders.Percentage Held by Institutions61.24% of the stock of Nexentis Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Nexentis Technologies' insider trading history. Receive NXTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nexentis Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NXTS Stock News HeadlinesNexentis Technologies Inc.: Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery CampaignJuly 28, 2026 | finanznachrichten.deNexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery CampaignJuly 28, 2026 | globenewswire.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.August 31 at 1:00 AM | Banyan Hill Publishing (Ad)Nexentis Technologies Earnings Estimates, EPS & Revenue | NASDAQ:NXTSJuly 18, 2026 | benzinga.comNexentis Technologies Insider Trading Activity | NASDAQ:NXTS | BenzingaJuly 17, 2026 | benzinga.comNexentis Technologies Inc NXTSJuly 7, 2026 | morningstar.comMNexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI InitiativeJuly 7, 2026 | globenewswire.comNexentis Shares Rise After Solar Project Monetisation Agreement (NXTS)June 29, 2026 | msn.comSee More Headlines NXTS Stock Analysis - Frequently Asked Questions How have NXTS shares performed this year? Nexentis Technologies' stock was trading at $11.76 at the beginning of the year. Since then, NXTS stock has decreased by 84.7% and is now trading at $1.80. How were Nexentis Technologies' earnings last quarter? Nexentis Technologies Inc. (NASDAQ:NXTS) announced its quarterly earnings results on Thursday, November, 13th. The company reported ($58.03) earnings per share (EPS) for the quarter. The company had revenue of $0.07 million for the quarter. When did Nexentis Technologies' stock split? Shares of Nexentis Technologies reverse split on the morning of Wednesday, April 8th 2026.The 1-7 reverse split was announced on Wednesday, April 8th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 8th 2026. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. Who are Nexentis Technologies' major shareholders? Top institutional shareholders of Nexentis Technologies include Yorkville Advisors Global LP (1.13%). How do I buy shares of Nexentis Technologies? Shares of NXTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nexentis Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nexentis Technologies investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Oracle (ORCL), Palo Alto Networks (PANW), Qualcomm (QCOM), Analog Devices (ADI) and Adobe (ADBE). Company Calendar Last Earnings11/13/2025Today8/31/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 NXTS's financial health is in the Yellow zone, according to TradeSmith. NXTS has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:NXTS Previous SymbolNASDAQ:NITO CIK1789192 Webwww.n2off.htmline.com Phone972-347-468-9583FaxN/AEmployees2Year FoundedN/AProfitability EPS (Trailing Twelve Months)($96.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$4 million Net MarginsN/A Pretax Margin-25,363.63% Return on Equity-304.79% Return on Assets-178.91% Debt Debt-to-Equity Ratio0.12 Current Ratio3.72 Quick Ratio3.72 Sales & Book Value Annual Sales$210 thousand Price / Sales12.43 Cash FlowN/A Price / Cash FlowN/A Book Value$39.70 per share Price / Book0.05Miscellaneous Outstanding Shares1,450,000Free Float1,358,000Market Cap$2.61 million OptionableN/A Beta1.83 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:NXTS) was last updated on 8/31/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexentis Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexentis Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
